J&J to Pay $2.2B to Settle Marketing Allegations

Associated Press Videos
Johnson & Johnson and its subsidiaries have agreed to pay over $2.2 billion to resolve criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients. (Nov. 4)
View Comments (0)

Recommended for You